Colorectal cancer and immunity: what we know and perspectives. - Test2 - elhamkhani - TriplyDB

Colorectal cancer and immunity: what we know and perspectives.

Colorectal cancer and immunity: what we know and perspectives.

http://www.wikidata.org/entity/Q37697520

about

The Immunogenicity of Colorectal Cancer in Relation to Tumor Development and Treatment Single Nucleotide Polymorphisms as Prognostic and Predictive Factors of Adjuvant Chemotherapy in Colorectal Cancer of Stages I and II Immune Checkpoint Modulation in Colorectal Cancer: What's New and What to Expect Th22 cell accumulation is associated with colorectal cancer development Myeloid STAT3 promotes formation of colitis-associated colorectal cancer in mice Phenotypic analysis of T cells infiltrating colon cancers: Correlations with oncogenetic status.CXCL4 mediates tumor regrowth after chemotherapy by suppression of antitumor immunity Proteomic screening identifies calreticulin as a miR-27a direct target repressing MHC class I cell surface exposure in colorectal cancer.Antitumor effects of oncolytic herpes simplex virus type 2 against colorectal cancer in vitro and in vivo.Spatial distribution of FoxP3+ and CD8+ tumour infiltrating T cells reflects their functional activity.Profile of gene expression of TLR-signaling pathways in colorectal cancer tissues.Cancer-associated fibroblasts connect metastasis-promoting communication in colorectal cancer.Novel avenues in immunotherapies for colorectal cancer.Enhancement of NK cells proliferation and function by Shikonin.Diabetes and the risk of biochemical recurrence in patients with treated localized prostate cancer: a meta-analysis.The Immune Revolution in Gastrointestinal Tumours: Leading the Way or Just Following?Checkpoint inhibition for colorectal cancer: progress and possibilities.Contribution of resident and recruited macrophages to the photodynamic intervention of colorectal tumor microenvironment.Immunotherapy of colorectal cancer: new perspectives after a long path.Functional impairment of infiltrating T cells in human colorectal cancer.Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer.Neoadjuvant chemoradiotherapy of rectal carcinoma : Baseline hematologic parameters influencing outcomes.Dendritic Cells Transfected with a DNA Construct Encoding Tumour-associated Antigen Epitopes Induce a Cytotoxic Immune Response Against Autologous Tumour Cells in a Culture of Mononuclear Cells from Colorectal Cancer Patients.An Atlas of Human Regulatory T Helper-like Cells Reveals Features of Th2-like Tregs that Support a Tumorigenic Environment.Peritoneal carcinomatosis of colorectal cancer is characterized by structural and functional reorganization of the tumor microenvironment inducing senescence and proliferation arrest in cancer cells.The clinical impact of tumour-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: A cohort study.Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy.Immunotherapy and gene therapy as novel treatments for cancer.Stromal and intraepithelial tumor-infiltrating lymphocytes in colorectal carcinoma.TAP1 down-regulation elicits immune escape and poor prognosis in colorectal cancer.Strategy to targeting the immune resistance and novel therapy in colorectal cancer.Lycium barbarum Polysaccharide Promotes Maturation of Dendritic Cell via Notch Signaling and Strengthens Dendritic Cell Mediated T Lymphocyte Cytotoxicity on Colon Cancer Cell CT26-WT.The prostate cancer immunome: In silico functional analysis of antigenic proteins from microarray profiling with IgG.Immunotherapy in Gastrointestinal Cancers.Fecal Galectin-3: A New Promising Biomarker for Severity and Progression of Colorectal Carcinoma.Transcriptomics analysis reveals new insights in E171-induced molecular alterations in a mouse model of colon cancer.Immunotherapy in Melanoma, Gastrointestinal (GI), and Pulmonary Malignancies Stem and immune cells in colorectal primary tumour: Number and function of subsets may diagnose metastasis Current approaches to immunotherapy in noncolorectal gastrointestinal malignancies

P2860

Q26745580-D6644069-620D-4C06-BA4A-ABECC0A789A4 Q26765344-178AA62B-3EEC-4C57-881A-D9A6BF3CD357 Q26775578-60103DC4-18E9-4413-A0F9-E063220DA26D Q35375460-D24C9015-3D83-4286-AC84-B48D27B7311A Q35799053-EBA7A0A6-F0E0-443D-AA50-AB476AA76C34 Q36060273-09D7FA48-9E7A-42E8-BFE9-EAD64CE495A7 Q36843770-619EC3BD-888B-4D70-A2B3-0A142FEB03D2 Q36847539-90782F0D-756C-4B2D-89AE-ABF9F1248914 Q37641458-8136FC10-AEDB-4D14-B706-5C8BBBA216A9 Q37645030-1206C9E2-DAA8-45B5-BFE1-9FFEE56AD5FE Q38370227-82EB6D1C-9DA0-4A52-B0A9-303DD1112CA4 Q38411234-1908545C-E68D-4454-89AE-96AE11C80283 Q38637906-A0BB6D74-0B5F-481A-B4B6-A75CC79DC04D Q38711887-BEEE58C8-B3D7-4B01-8F5E-171F8E698C97 Q38832550-BFEBBE85-2081-4215-9054-15411B34A25B Q38835601-ABB070A8-B924-46CC-9744-DB99BE97F60F Q38838641-AAE65E61-5EEF-4F8E-AB1F-7855F878DEEB Q38847434-2033680D-9701-43B3-8A4C-717E74202E7E Q39043413-EB9E9F32-E2F8-42D2-A0E6-E3391303508F Q39079676-C8B3583C-215F-410B-919A-D154425B38D6 Q39120155-7070DB38-D209-4398-820B-4E3904FE494A Q39703037-633355E7-6D59-4BC3-81F6-09F88DD5E825 Q40947471-3F158206-4F7F-439D-A4DA-4B857685370A Q41139626-55476DEF-345D-4EDB-999D-CECE51080E32 Q42149012-6F5CC058-4DA7-4B6C-BEAD-BC668F51BE24 Q42359699-E703B301-FF0D-415B-93DF-A90A953EE07E Q42644178-38A74149-60BE-4CD3-A5BB-480B59E99527 Q45875535-70D46249-7363-43E6-9566-E3D432A1FF25 Q47123925-7BF85569-B264-4BA9-9168-ECF4AA44FAC7 Q47393414-FF5EAB76-C290-4495-B760-93A8AFA2A4F0 Q52320729-253BAC5F-423B-4C63-8FDD-34840D86690B Q52606111-C3A71FD6-9689-42A8-92BA-D920761CA8A0 Q52874472-E902D5B6-D373-45B6-A6CA-D781D7A91E28 Q53183990-4DCC3B65-BA82-4510-ADBC-5113BB5F1AEB Q55259032-0D559F60-E330-4BAF-9D1B-C40819B1BEB3 Q55430424-99211F76-1E0D-4463-977F-0577A1728F21 Q56896166-D548016F-88C5-4B6D-A3A5-B94AC07FAC0D Q58199154-0967AC78-E12E-416D-95C8-68748C71D101 Q58594584-1DD037C3-E83E-415B-BEBD-770C95A23721

P2860

Colorectal cancer and immunity: what we know and perspectives.

http://www.wikidata.org/entity/Q37697520

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Colorectal cancer and immunity: what we know and perspectives.

@en

Colorectal cancer and immunity: what we know and perspectives.

@nl

type

label

Colorectal cancer and immunity: what we know and perspectives.

@en

Colorectal cancer and immunity: what we know and perspectives.

@nl

prefLabel

Colorectal cancer and immunity: what we know and perspectives.

@en

Colorectal cancer and immunity: what we know and perspectives.

@nl

P1433

Q37697520-C1487F35-EB1C-46C4-91C0-D8CD004556B0

P1476

Q37697520-B559265B-E481-456A-A8C5-3A7FCF6F2E1A

P2093

Q37697520-894CF421-52BD-428B-BAED-3F5DDFAF25AF

Q37697520-97D78268-721E-4DCA-91B3-806D086F0A96

Q37697520-9AA31D74-6576-464A-A2E7-B0C9CF4A4591

Q37697520-B934E2AF-101C-45D9-A088-D643DA0BD7B9

P2860

Q37697520-0BE491B9-CCFB-4920-A240-314C7E171E79

Q37697520-0EA5D6B7-30ED-4E66-966F-B99397595ECF

Q37697520-0FB16C37-FD24-4CA8-9A4A-07BB55182528

Q37697520-128C1E1B-57DB-4E56-A785-3169CF487ADD

Q37697520-167D5CCB-932F-45C7-96AF-B0E876CD7846

Q37697520-17494AA3-A24D-4AA3-9FE0-A18129BC84ED

Q37697520-29BD34EA-5B92-4BD5-A0C1-E1323400DA06

Q37697520-2D8C77F1-1DB7-4EF4-8BEB-C31E56EE684C

Q37697520-2E76B3EE-3F97-4265-B290-499CFB19C8F8

Q37697520-35E809BF-3647-4E88-B9AE-2E1703DC2FA9

P304

Q37697520-F294D953-0405-4B31-BF89-8C195135A90B

P31

Q37697520-4F41FB83-18DA-4856-8931-AF7F107D733E

P356

Q37697520-6B602231-8D92-43FF-A1C9-C873D6EA2BC1

P407

Q37697520-D8B59201-5A34-4D1C-8AFF-08F3FEB14F3D

P433

Q37697520-F4607C4D-71C8-4E30-80C2-95EC86C5A08D

P478

Q37697520-6E555478-ED4B-416B-8C1A-0CC6C78F781C

P50

Q37697520-2E6E0B77-6D18-4AED-83C2-0A4A280F7F81

Q37697520-8D6DE1E9-F776-43CE-8D23-E2CD4976C04A

Q37697520-F8F185B1-D8B8-46BB-B745-A64DDB2E206B

P577

Q37697520-787D7C99-5323-4DA3-A375-68B050F24108

P5875

Q37697520-B2FF3F1B-2427-4FDA-B159-56C094BAD463

P698

Q37697520-7B4CDFD6-7AB3-40CD-8BEA-37175E5D8D83

P921

Q37697520-D9FD868F-8C2C-4114-8B7F-99BD82B5F06B

P932

Q37697520-6792483F-70F5-498F-B883-F1777ABB7214

P356

WJG.V20.I14.3738

P1433

World Journal of Gastroenterology

P1476

Colorectal cancer and immunity: what we know and perspectives.

@en

P2093

Elie Marcheteau

http://www.w3.org/2001/XMLSchema#string

Orianne Colussi

http://www.w3.org/2001/XMLSchema#string

Simon Pernot

http://www.w3.org/2001/XMLSchema#string

Thibault Voron

http://www.w3.org/2001/XMLSchema#string

P2860

Nivolumab plus ipilimumab in advanced melanoma.

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues

Cancer immunoediting: from immunosurveillance to tumor escape

HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells

Calreticulin exposure dictates the immunogenicity of cancer cell death

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

P304

3738-3750

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V20.I14.3738

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262384415

http://www.w3.org/2001/XMLSchema#string

P698

24833840

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

3983433

http://www.w3.org/2001/XMLSchema#string